Skip to main content
Micro-Tech (Nanjing) Co.,Ltd logo

Micro-Tech (Nanjing) Co.,Ltd — Investor Relations & Filings

Ticker · 688029 ISIN · CNE100003MG1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2022-04-25 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 688029

About Micro-Tech (Nanjing) Co.,Ltd

https://www.micro-tech.com.cn/

Micro-Tech (Nanjing) Co., Ltd. specializes in the research, development, and manufacturing of minimally invasive medical devices. The company focuses on providing advanced solutions for gastroenterology, respiratory medicine, and orthopedics. Its product portfolio includes a wide range of endoscopic diagnostic and therapeutic tools such as biopsy forceps, disposable hemoclips, biliary and esophageal stents, and specialized instruments for Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD). Micro-Tech emphasizes innovation and quality, maintaining international certifications to serve a global healthcare market. By integrating precision engineering with clinical needs, the company aims to improve patient outcomes and procedural efficiency for medical professionals worldwide.

Recent filings

Filing Released Lang Actions
南微医学科技股份有限公司关于使用部分超募资金永久补充流动资金的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from a company regarding the use of part of its over-raised funds to permanently supplement working capital. It includes details about board and supervisory committee meetings, independent director opinions, and sponsor institution verification. The document references regulatory approvals and compliance with listing rules. It is a formal disclosure about a financing-related decision, specifically about the use of raised capital, but it does not contain financial statements or detailed financial results. The document length is about 3,213 characters, which is relatively short and focused on a specific capital usage announcement. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2022-04-25 Chinese
南微医学科技股份有限公司第三届监事会第六次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement of resolutions passed at the sixth meeting of the third Supervisory Board of Nanwei Medical Technology Co., Ltd. It includes approvals of various reports and proposals such as the 2021 internal control evaluation report, 2021 social responsibility report, adjustments to fundraising projects, financial budget, 2021 annual report and summary, 2021 financial statements, 2022 first quarter report, and other governance and financial matters. The document references the 2021 annual report and other reports but does not contain the full annual report itself; rather, it states that these reports are published on the Shanghai Stock Exchange website. The document is a formal meeting resolution announcement by the Supervisory Board, summarizing their approvals and opinions on these reports and proposals, and indicating that some items will be submitted to the 2021 annual shareholders meeting for approval. The document length is 4783 characters, which is relatively short for a full annual report but appropriate for a meeting resolution announcement. Given the content and context, this document is best classified as a Regulatory Filing (RNS) because it is an official regulatory announcement of Supervisory Board meeting resolutions and approvals, referencing but not containing the full reports themselves. It is not the full Annual Report (10-K) or Interim Report (IR), nor is it a Proxy Solicitation or Voting Results announcement. Therefore, the most accurate classification is Regulatory Filings (RNS).
2022-04-25 Chinese
南京证券股份有限公司关于南微医学科技股份有限公司增加募投项目实施地点之专项核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed verification opinion from the sponsor institution (Nanjing Securities) regarding the addition of implementation locations for investment projects funded by proceeds from an initial public offering (IPO) of Nanwei Medical Technology Co., Ltd. It references regulatory approvals, fundraising amounts, and compliance with relevant securities regulations. The content focuses on the use and management of raised funds, project implementation, and compliance with regulatory requirements. It is not a full financial report, earnings release, or management discussion, but rather a regulatory compliance and verification document related to capital use and fundraising projects. This fits best under Capital/Financing Update (CAP), as it deals with updates on fundraising project implementation and capital use.
2022-04-25 Chinese
中天运会计师事务所（特殊普通合伙）关于南微医学科技股份有限公司2021年度募集资金存放与使用情况的专项报告
Regulatory Filings
2022-04-25 Chinese
南微医学科技股份有限公司关于增加募投项目实施地点的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the addition of implementation locations for certain fundraising investment projects. It discusses details about the use of raised funds, approvals by the board and supervisory committees, and opinions from independent directors and the sponsoring institution. The document does not contain financial statements or detailed financial performance data but rather updates on the use and management of previously raised capital. It is not a full annual or interim report, nor is it a call transcript or earnings release. It is not a regulatory certification or legal proceeding. The content fits best under Capital/Financing Update (CAP) as it relates to updates on fundraising project implementation and capital use without changing the purpose of the funds.
2022-04-25 Chinese
南微医学科技股份有限公司独立董事关于公司第三届董事会第七次会议相关事项的事前认可意见
Regulatory Filings
2022-04-25 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.